Patent US4847296A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4847296A Expired / Lapsed US ⏱️ 0.0 years remaining

Triglyceride preparations for the prevention of catabolism

Assignee: Individual
•
Filing: 1987-03-20
•
Granted: 1989-07-11
•
Expires: 2007-03-20
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Chemically synthesized structured triglycerides (lipids) for enteral administration as the lipid calorie source, is subjects undergoing severe metabolic stress.

Inventors

  • 👤 Vigen K. Babayan
  • 👤 George L. Blackburn
  • 👤 Bruce R. Bistrian

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 07:44
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/21; A61K31/215; A61K31/22; A61K31/23

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 100 words
A method of preventing catabolism and increasing protein synthesis in a subject undergoing metabolic stress, which comprises administering enterally to the subject from about 0.3 gms of fat/Kg of body weight/day to about 4.0 gms of fat/Kg of body weight/day of a synthetic structured lipid of the formula ##STR2## wherein R 1 and R 2 may be independently a C 6 to C 24 acid provided that one of R 1 , R 2 or R 3 is a C 12 acid, and one of R 1 , R 2 and R 3 is omega 6 or omega 3 acid.
Claim 2
Independent Claim 100 words
A method of preventing catabolism and increasing protein synthesis in a subject undergoing metabolic stress, which comprises administering enterally to the subject from about 0.3 gms of fat/Kg of body weight/day to about 4.0 gms of fat/Kg of body weight/day of a synthetic structured lipid of the formula ##STR2## wherein R 1 and R 2 may be independently a C 6 to C 24 acid provided that one of R 1 , R 2 or R 3 is a C 12 acid, and one of R 1 , R 2 and R 3 is omega 6 or omega 3 acid.
Claim 3
Dependent Claim 55 words
The method according to claim 1 wherein the synthetic structured lipid is a rearranged mixture of a kernel type oil rich in fatty acids C 6 -C 12 and long chain triglycerides (LCT) oils having a percent composition of MCT to LCT 70 to 30%, 80 to 20%, 85 to 15% or 90 to 10%.
Claim 4
Dependent Claim 22 words
The method according to claim 2 wherein the percent composition of MCT to LCT is 80 to 20% or 85 to 15%.
Claim 5
Dependent Claim 32 words
The method according to claim 2 wherein the structured lipid comprises a medium chain triglyceride having a high lauric acid content and the long chain triglyceride has a high polyunsaturated acid content.
Claim 6
Dependent Claim 48 words
The method according to claim 4 wherein the medium chain triglyceride oils are babassu oil, coconut oil, cohune oil, palm kernel oil, tucum oil, and fractions thereof, and the long chain triglyceride oils are corn oil, peanut oil, safflower oil, soybean oil, sunflower seed oil and fish oil.
Claim 7
Dependent Claim 21 words
The method according to claim 5 wherein the structured lipid is prepared from a fractionated palm kernel oil and soybean oil.
Claim 8
Dependent Claim 23 words
The method according to claim 5 wherein the structured lipid is prepared from a mixture of 80% coconut oil and 20% soybean oil.
Claim 9
Dependent Claim 79 words
A pharmaceutical composition for enteral administration in preventing catabolism and increasing protein synthesis in a subject undergoing metabolic stress which comprises a structured lipid of the formula ##STR3## wherein R 1 and R 2 may be independently a C 6 to C 24 acid provided that one of R 1 , R 2 or R 3 is a C 12 acid, and one of R 1 , R 2 and R 3 is omega 6 or omega 3 acid.
Claim 10
Dependent Claim 79 words
A pharmaceutical composition for enteral administration in preventing catabolism and increasing protein synthesis in a subject undergoing metabolic stress which comprises a structured lipid of the formula ##STR3## wherein R 1 and R 2 may be independently a C 6 to C 24 acid provided that one of R 1 , R 2 or R 3 is a C 12 acid, and one of R 1 , R 2 and R 3 is omega 6 or omega 3 acid.
Claim 11
Dependent Claim 37 words
The pharmaceutical composition according to claim 8 wherein the structured lipid is prepared from a medium chain triglyceride oil having a high lauric acid content and a long chain triglyceride oil having a high polyunsaturated acid content.
Claim 12
Dependent Claim 49 words
The pharmaceutical composition according to claim 8 wherein the medium chain triglyceride oils are babassu oil, coconut oil, cohune oil, palm kernel oil, tucum oil, and fractions thereof, and the long chain triglyceride oils and corn oil, peanut oil, safflower oil, soybean oil, sunflower seed oil and fish oil.
Claim 13
Dependent Claim 22 words
The pharmaceutical composition according to claim 10 wherein the structured lipid is prepared from a fractionated palm kernel oil and soybean oil.
Claim 14
Dependent Claim 24 words
The pharmaceutical composition according to claim 10 wherein the structured lipid is prepared from a mixture of 80% coconut oil and 20% soybean oil.
Claim 15
Dependent Claim 23 words
The pharmaceutical composition according to claim 12 containing amino acids, vitamins and minerals in amounts effective for the treatment of the stressed subject.

References Cited (Backward Citations)

US4423072A Cited
US4481657A Cited
US4528197A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-07-10 1993-01-09 1993-07-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-07-10 1997-01-09 1997-07-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-07-10 2001-01-09 2001-07-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag